Urinary steroid profiling: a powerful method for the diagnosis of abnormal steroidogenesis

References

• Horning EC. Gas phase chromatography of Steroids, Springer, New York, NY, USA 1968.p. 1-77
   Google Scholar
• Shackleton CH, Taylor NF. Identification of the androstenetriolones and androstenetetrols present in the urine of infants. J Steroid Biochem 1975;6(10):1393-9
   Google Scholar
• Taylor N, Sharma S, Giffin F, et al. Urinary excretion of adrenocortical steroid metabolites by pre-term human infants: trends from birth until 3 months post term. Endocr Res 1996;22(4):741-9
   PubMed Web of Science ®Google Scholar
• Homma K, Hasegawa T, Masumoto M, et al. Reference values for urinary steroids in Japanese newborn infants: gas chromatography/mass spectrometry in selected ion monitoring. Endocr J 2003;50(6):783-92
   Google Scholar
• Honour JW. Urinary steroid profile analysis. Clin Chim Acta 2001;313(1-2):45-50
   Google Scholar
• Wudy SA, Hartmann MF. Gas chromatography-mass spectrometry profiling of steroids in times of molecular biology. Horm Metab Res 2004;36(6):415-22
   Google Scholar
• Krone N, Hughes BA, Lavery GG, et al. Gas chromatography/mass spectrometry (GC/MS. remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J. Steroid Biochem. Mol Biol 2010;121(3-5):496-504
   Google Scholar
• Rauh M. Steroid measurement with LC-MS/MS. Application examples in pediatrics. J Steroid Biochem Mol Biol 2010;121(3-5):520-7
   PubMed Web of Science ®Google Scholar
• McDonald JG, Matthew S, Auchus RJ. Steroid profiling by gas chromatography-mass spectrometry and high performance liquid chromatography-mass spectrometry for adrenal diseases. Horm Cancer 2011;2(6):324-32
   PubMedGoogle Scholar
• Kulle AE, Welzel M, Holterhus PM, Riepe FG. Principles and clinical applications of liquid chromatography - tandem mass spectrometry for the determination of adrenal and gonadal steroid hormones. J Endocrinol Invest 2011;34(9):702-8
   Google Scholar
• Taylor NF. Urinary steroid profiling. Methods Mol Biol 2013;1065:259-76
   Google Scholar
• Chan AO, Shek CC. Urinary steroid profiling in the diagnosis of congenital adrenal hyperplasia and disorders of sex development: experience of a urinary steroid referral centre in Hong Kong. Clin Biochem 2013;46(4-5):327-34
   Google Scholar
• Wooding KM, Auchus RJ. Mass spectrometry theory and application to adrenal diseases. Mol Cell Endocrinol 2013;371(1-2):201-7
   Google Scholar
• Miller WL. Steroid hormone synthesis in mitochondria. Mol Cell Endocrinol 2013;379(1-2):62-73
   PubMed Web of Science ®Google Scholar
• Caulfield MP, Lynn T, Gottschalk ME, et al. The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J Clin Endocrinol Metab 2002;87(8):3682-90
   PubMed Web of Science ®Google Scholar
• Wudy SA, Hartmann M, Homoki J. Hormonal diagnosis of 21-hydroxylase deficiency in plasma and urine of neonates using benchtop gas chromatography-mass spectrometry. J Endocrinol 2000;165(3):679-83
   Google Scholar
• Nimkarn S, Lin-Su K, New MI. Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 2009;38(4):699-718
   Google Scholar
• Homma K, Hasegawa T, Takeshita E, et al. Elevated urine pregnanetriolone definitively establishes the diagnosis of classical 21-hydroxylase deficiency in term and preterm neonates. J Clin Endocrinol Metab 2004;89(12):6087-91
   Google Scholar
• Christakoudi S, Cowan DA, Taylor NF. Steroids excreted in urine by neonates with 21-hydroxylase deficiency: characterization, using GC-MS and GC-MS/MS, of the D-ring and side chain structure of pregnanes and pregnenes. Steroids 2010;75(1):34-52
   Google Scholar
• Christakoudi S, Cowan DA, Taylor NF. Steroids excreted in urine by neonates with 21-hydroxylase deficiency. 2. Characterization, using GC-MS and GC-MS/MS, of pregnanes and pregnenes with an oxo- group on the A- or B-ring. Steroids 2012;77(5):382-93
   Google Scholar
• Christakoudi S, Cowan DA, Taylor NF. Steroids excreted in urine by neonates with 21-hydroxylase deficiency. 3. Characterization, using GC-MS and GC-MS/MS, of androstanes and androstenes. Steroids 2012;77(13):1487-501
   Google Scholar
• Christakoudi S, Cowan DA, Taylor NF. Steroids excreted in urine by neonates with 21-hydroxylase deficiency. 4. Characterization, using GC-MS and GC-MS/MS, of 11oxo-pregnanes and 11oxo-pregnenes. Steroids 2013;78(5):468-75
   Google Scholar
• Christakoudi S, Cowan DA, Christakudis G, Taylor NF. 21-Hydroxylase deficiency in the neonate - trends in steroid anabolism and catabolism during the first weeks of life. J. Steroid Biochem. Mol Biol 2013;138:334-47
   Google Scholar
• Pandey AV, Flück CE, Huang N, et al. P450 oxidoreductase deficiency: a new disorder of steroidogenesis affecting all microsomal P450 enzymes. Endocr Res 2004;30(4):881-8
   PubMed Web of Science ®Google Scholar
• Miller WL, Agrawal V, Sandee D, et al. Consequences of POR mutations and polymorphisms. Mol Cell Endocrinol 2011;336(1-2):174-9
   Google Scholar
• Flück CE, Pandey AV. Clinical and biochemical consequences of p450 oxidoreductase deficiency. Endocr Dev 2011;20:63-79
   PubMedGoogle Scholar
• Miller WL, Huang N, Agrawal V, Giacomini KM. Genetic variation in human P450 oxidoreductase. Mol Cell Endocrinol 2009;300(1-2):180-4
   PubMed Web of Science ®Google Scholar
• Koyama Y, Homma K, Fukami M, et al. Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/tetrahydroxycortisone ratio and 11β-hydroxyandrosterone. Clin Chem 2012;58(4):741-7
   Google Scholar
• Reisch N, Idkowiak J, Hughes BA, et al. Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency. J Clin Endocrinol Metab 2013;98(3):E528-36
   PubMed Web of Science ®Google Scholar
• Flück CE, Meyer-Böni M, Pandey AV, et al. Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. Am J Hum Genet 2011;89(2):201-18
   PubMed Web of Science ®Google Scholar
• Nimkarn S, New MI. Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia. Trends Endocrinol Metab 2008;19(3):96-9
   Web of Science ®Google Scholar
• Reisch N, Högler W, Parajes S, et al. A diagnosis not to be missed: nonclassic steroid 11β-hydroxylase deficiency presenting with premature adrenarche and hirsutism. J Clin Endocrinol Metab 2013;98(10):E1620-5
   Google Scholar
• Simard J, Ricketts ML, Gingras S, et al. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family. Endocr Rev 2005;26(4):525-82
   PubMed Web of Science ®Google Scholar
• Jeandron DD, Sahakitrungruang T. A novel homozygous Q334X mutation in the HSD3B2 gene causing classic 3β-hydroxysteroid dehydrogenase deficiency: an unexpected diagnosis after a positive newborn screen for 21-hydroxylase deficiency. Horm Res Paediatr 2012;77(5):334-8
   Google Scholar
• Neres MS, Auchus RJ, Shackleton CH, Kater CE. Distinctive profile of the 17-hydroxylase and 17,20-lyase activities revealed by urinary steroid metabolomes of patients with CYP17 deficiency. Arq Bras Endocrinol Metabol 2010;54(9):826-32
   Google Scholar
• Van Den Akker EL, Koper JW, Boehmer AL, et al. Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency. J Clin Endocrinol Metab 2002;87(12):5714-21
   PubMed Web of Science ®Google Scholar
• Sherbet DP, Tiosano D, Kwist KM, et al. CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding. J Biol Chem 2003;278(49):48563-9
   Google Scholar
• Kok RC, Timmerman MA, Wolffenbuttel KP, et al. Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X. J Clin Endocrinol Metab 2010;95(3):994-9
   Google Scholar
• Idkowiak J, Randell T, Dhir V, et al. A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency. J Clin Endocrinol Metab 2012;97(3):E465-75
   PubMed Web of Science ®Google Scholar
• Ulick S, Wang JZ, Morton DH. The biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone. J Clin Endocrinol Metab 1992;74(6):1415-20
   Google Scholar
• White PC. Aldosterone synthase deficiency and related disorders. Mol Cell Endocrinol 2004;217(1-2):81-7
   Google Scholar
• Kondo E, Nakamura A, Homma K, et al. Two novel mutations of the CYP11B2 gene in a Japanese patient with aldosterone deficiency type 1. Endocr J 2013;60(1):51-5
   Google Scholar
• Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992;355(6357):262-5
   PubMed Web of Science ®Google Scholar
• Mulatero P, di Cella SM, Monticone S, et al. 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J Clin Endocrinol Metab 2012;97(3):881-9
   Google Scholar
• Kamrath C, Maser-Gluth C, Haag C, Schulze E. Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. Horm Res Paediatr 2011;76(2):93-8
   Google Scholar
• Berra M, Williams EL, Muroni B, et al. Recognition of 5α-reductase-2 deficiency in an adult female 46XY DSD clinic. Eur J Endocrinol 2011;164(6):1019-25
   PubMed Web of Science ®Google Scholar
• Chan AO, But BW, Lau GT, et al. Diagnosis of 5alpha-reductase 2 deficiency: a local experience. Hong Kong Med J 2009;15(2):130-5
   Google Scholar
• Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 1993;14(5):577-93
   PubMed Web of Science ®Google Scholar
• Chan AO, But BW, Lee CY, et al. Diagnosis of 5α-reductase 2 deficiency: is measurement of dihydrotestosterone essential? Clin Chem 2013;59(5):798-806
   Google Scholar
• Perry RJ, Novikova E, Wallace AM, Donaldson MD. Pitfalls in the diagnosis of 5α-reductase type 2 deficiency during early infancy. Horm Res Paediatr 2011;75(5):380-2
   Google Scholar
• Lavery GG, Walker EA, Tiganescu A, et al. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency. J Clin Endocrinol Metab 2008;93(10):3827-32
   Google Scholar
• Lavery GG, Idkowiak J, Sherlock M, et al. Novel H6PDH mutations in two girls with premature adrenarche: ’apparent’ and ’true’ CRD can be differentiated by urinary steroid profiling. Eur J Endocrinol 2013;168(2):K19-26
   Google Scholar
• Nimkarn S. Apparent mineralocorticoid excess - update. Adv Exp Med Biol 2011;707:47-8
   Google Scholar
• White PC, Mune T, Agarwal AK. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997;18(1):135-56
   Google Scholar
• Turpeinen U, Markkanen H, Sane T, Hämäläinen E. Determination of free tetrahydrocortisol and tetrahydrocortisone ratio in urine by liquid chromatography-tandem mass spectrometry. Scand J Clin Lab Invest 2006;66(2):147-59
   PubMed Web of Science ®Google Scholar
• King SR, Bhangoo A, Stocco DM. Functional and physiological consequences of StAR deficiency: role in lipoid congenital adrenal hyperplasia. Endocr Dev 2011;20:47-53
   Google Scholar
• Hauffa B, Hiort O. P450 side-chain cleavage deficiency--a rare cause of congenital adrenal hyperplasia. Endocr Dev 2011;20:54-62
   Google Scholar
• Achermann JC, Meeks JJ, Jameson JL. Phenotypic spectrum of mutations in DAX-1 and SF-1. Mol Cell Endocrinol 2001;185(1-2):17-25
   Google Scholar
• Fassnacht M, Kroiss M, Allolio B. Update in adrenocortical carcinoma. J Clin Endocrinol Metab 2013;98(12):4551-64
   PubMed Web of Science ®Google Scholar
• Tiu SC, Chan AO, Taylor NF, et al. Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours. Hong Kong Med J 2009;15(6):463-70
   PubMedGoogle Scholar
• Arlt W, Biehl M, Taylor AE, et al. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab 2011;96(12):3775-84
   PubMed Web of Science ®Google Scholar
• Jin S, Wada N, Takahashi Y, et al. Quantification of urinary 18-hydroxycortisol using LC-MS/MS. Ann Clin Biochem 2013;50(5):450-6
   Google Scholar
• Palermo M, Marazzi MG, Hughes BA, et al. Human Delta4-3-oxosteroid 5beta-reductase (AKR1D1. deficiency and steroid metabolism. Steroids 2008;73(4):417-23
   PubMed Web of Science ®Google Scholar
• Ueki I, Kimura A, Chen HL, et al. SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta4-steroid 5beta-reductase deficiency. J Gastroenterol Hepatol 2009;24(5):776-85
   Google Scholar
• Seki Y, Mizuochi T, Kimura A, et al. Two neonatal cholestasis patients with mutations in the SRD5B1 (AKR1D1) gene: diagnosis and bile acid profiles during chenodeoxycholic acid treatment. J Inherit Metab Dis 2013;36(3):565-73
   Google Scholar
• Nowaczyk MJ, Irons MB. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology. Am J Med Genet C Semin Med Genet 2012;160C(4):250-62
   Google Scholar
• Shackleton C, Roitman E, Guo LW, et al. Identification of 7(8) and 8(9) unsaturated adrenal steroid metabolites produced by patients with 7-dehydrosterol-delta7-reductase deficiency (Smith-Lemli-Opitz syndrome). J Steroid Biochem Mol Biol 2002;82(2-3):225-32
   Google Scholar
• Shackleton CH, Marcos J, Palomaki GE, et al. Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS). Am J Med Genet A 2007;143A(18):2129-36
   Google Scholar
• Cho HJ, Kim JD, Lee WY, et al. Quantitative metabolic profiling of 21 endogenous corticosteroids in urine by liquid chromatography-triple quadrupole-mass spectrometry. Anal Chim Acta 2009;632(1):101-8
   Google Scholar
• Arboleda VA, Lee H, Sánchez FJ, et al. Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development. Clin Genet 2013;83(1):35-43
   Google Scholar